Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Neurocrine Biosciences Inc (NBIX)  
$143.03 5.49 (3.99%) as of 4:30 Wed 5/1


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 93,430,000
Market Cap: 13.36(B)
Last Volume: 1,601,920 Avg Vol: 808,647
52 Week Range: $89.53 - $143.74
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  946
Guru Rank Value     : 0
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Neurocrine Biosciences is applying its capabilities into neuroscience to develop medicines for neurology, neuroendocrinology and neuropsychiatry-related disorders and diseases. Co.'s commercially available medicines include INGREZZA®, which provides a once-daily dosing treatment option for tardive dyskinesia and has three dosing options (40 mg, 60 mg and 80 mg capsules); and ONGENTYS®, which is a once-daily, peripherally acting Catechol-O-methyltransferase inhibitor utilized to prolong the duration of effect of levodopa, the primary treatment option for Parkinson's disease patients, during periods of the day where the effects of levodopa wear off and motor symptoms worsen.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 309,926 770,737 813,285 1,295,492
Total Sell Value $42,518,132 $101,765,228 $106,396,835 $159,503,766
Total People Sold 13 15 15 17
Total Sell Transactions 43 69 84 154
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 807
  Page 2 of 33  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Delaet Ingrid Chief Regulatory Officer   •       –      –    2024-02-28 4 OE $79.02 $517,107 D/D 6,544 9,051     -
   Benevich Eric Chief Commercial Officer   •       –      –    2024-02-28 4 AS $134.69 $10,101,608 D/D (75,000) 40,616 1%     
   Benevich Eric Chief Commercial Officer   •       –      –    2024-02-28 4 OE $43.24 $4,025,043 D/D 75,000 62,473     -
   Norwalk Leslie V Director   –       •      –    2024-02-27 4 AS $135.67 $1,085,388 D/D (8,000) 0 -0%     
   Norwalk Leslie V Director   –       •      –    2024-02-27 4 OE $84.95 $679,600 D/D 8,000 8,000     -
   Pops Richard F Director   –       •      –    2024-02-20 4 AS $132.47 $1,987,047 D/D (15,000) 29,512 3%     
   Pops Richard F Director   –       •      –    2024-02-20 4 OE $12.98 $194,700 D/D 15,000 44,512     -
   Gorman Kevin Charles Chief Executive Officer   •       •      –    2024-02-13 4 OE $35.99 $199,951 D/D 5,090 512,052     -
   Delaet Ingrid Chief Regulatory Officer   •       –      –    2024-02-13 4 AS $133.03 $95,253 D/D (716) 7,507 2%     
   Gano Kyle Chief Business Development Off   •       –      –    2024-02-13 4 AS $132.89 $179,674 D/D (1,352) 135,166 2%     
   Roberts Eiry Chief Medical Officer   •       –      –    2024-02-13 4 AS $132.96 $148,122 D/D (1,114) 23,716 2%     
   Boyer David W. Chief Corp. Affairs Officer   •       –      –    2024-02-13 4 AS $133.05 $240,996 D/D (1,811) 4,895 2%     
   Cooke Julie Chief Human Resources Officer   •       –      –    2024-02-13 4 AS $133.04 $105,902 D/D (796) 17,976 2%     
   Benevich Eric Chief Commercial Officer   •       –      –    2024-02-13 4 AS $133.01 $146,050 D/D (1,098) 40,616 2%     
   Abernethy Matt Chief Financial Officer   •       –      –    2024-02-13 4 AS $132.85 $179,612 D/D (1,352) 31,528 2%     
   Lippoldt Darin Chief Legal Officer   •       –      –    2024-02-13 4 AS $132.99 $146,028 D/D (1,098) 39,740 2%     
   Gorman Kevin Charles Chief Executive Officer   •       •      –    2024-02-13 4 AS $133.02 $376,700 D/D (2,832) 514,596 2%     
   Onyia Jude Chief Scientific Officer   •       –      –    2024-02-13 4 AS $132.94 $190,371 D/D (1,432) 13,128 2%     
   Boyer David W. Chief Corp. Affairs Officer   •       –      –    2024-02-08 4 AS $134.19 $179,830 D/D (1,328) 4,895 1%     
   Benevich Eric Chief Commercial Officer   •       –      –    2024-02-08 4 AS $134.19 $131,509 D/D (980) 39,631 1%     
   Gorman Kevin Charles Chief Executive Officer   •       •      –    2024-02-08 4 AS $134.15 $305,052 D/D (2,274) 506,962 1%     
   Roberts Eiry Chief Medical Officer   •       –      –    2024-02-08 4 AS $134.21 $131,522 D/D (980) 22,717 1%     
   Cooke Julie Chief Human Resources Officer   •       –      –    2024-02-08 4 AS $134.23 $179,995 D/D (1,329) 17,263 1%     
   Lippoldt Darin Chief Legal Officer   •       –      –    2024-02-08 4 AS $134.24 $122,289 D/D (911) 38,755 1%     
   Gano Kyle Chief Business Development Off   •       –      –    2024-02-08 4 AS $134.20 $131,519 D/D (980) 133,952 1%     
  807 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 33
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us